News Pig to human kidney transplantation hits a new milestone A pig kidney transplanted into a human patient has broken records by lasting for nine months, buying time until a human donor organ became available.
News Ipsen's M&A team strikes again, adding Memo in $700m deal Ipsen will pay up to €700m to take control of Memo Therapeutics and its drug for BK polyomavirus, which can lead to the failure of kidney transplants.
News Asahi Kasei buys antiviral firm Aicuris for €780m Asahi Kasei has agreed to buy Germany's Aicuris for around $920m, adding an antiviral drug it hopes will help drive its 2030 pharma sales to $1.9bn.
R&D Recent breakthroughs in 3D bioprinting: A look at trends and... 3D bioprinting technology is bringing a new revolutionary wave to the healthcare industry.
News First gene-edited pig liver transplant 'worked for 10 days' In a xenotransplant milestone, scientists have carried out the first transplant of a genetically modified pig liver into a brain-dead human patient.
News Eledon drug helps transplants 'cure' type 1 diabetes Eledon Pharmaceuticals has revealed that two patients with type 1 diabetes achieved a 'functional cure' after receiving a transplant of insulin-producing islet cells in combination with its
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.